[{"address1": "Wagistrasse 14", "city": "Schlieren", "zip": "8952", "country": "Switzerland", "phone": "41 44 755 77 00", "fax": "41 44 755 77 07", "website": "https://www.molecularpartners.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Molecular Partners AG, a clinical-stage biotechnology company, designs and develops designed ankyrin repeat proteins therapeutics for the treatment of oncology diseases in Switzerland. Its product pipeline comprises MP0317, which is in Phase 1 clinical trial for the treatment of advanced solid tumors; MP053, novel tetra-specific T cell-engaging DARPin, which is phase 1 clinical trial for the treatment of acute myeloid leukemia; and MP0712, a 212Pb Radio-DARPin therapy (RDT) candidate targeting the tumor-associated protein delta-like ligand 3 (DLL3) which is in preclinical trial to treat SCLC and neuroendocrine tumors. It also researches for Switch-DARPin T cell engager to treat CD3 x costim x; and Radio-DARPin Therapy to treat ovarian disease. In addition, the company develops MP0621, a molecular partners' first Switch-DARPin program, which is in preclinical trial designed to induce killing of hematopoietic stem cells (HSCs) as a next-generation conditioning regimen for HSC transplantation (HSCT); and Radio-DARPin Therapy (RDT) platform, a delivery system for effective and selective delivery of radioactive payloads to solid tumors. It has collaboration agreement with Orano Med SAS to develop novel Radio-DARPin therapeutics and an additional six targeted alpha therapeutics candidates. Molecular Partners AG was incorporated in 2004 and is headquartered in Schlieren, Switzerland.", "fullTimeEmployees": 153, "companyOfficers": [{"maxAge": 1, "name": "Dr. Patrick  Amstutz Ph.D.", "age": 49, "title": "Co-Founder, CEO, Member of Management Board & Director", "yearBorn": 1975, "fiscalYear": 2024, "totalPay": 808636, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Michael Tobias Stumpp Ph.D.", "age": 52, "title": "Co-Founder, Executive VP of Projects & Member of Management Board", "yearBorn": 1972, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Robert  Hendriks", "title": "Senior VP of Finance", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Alexander  Zurcher", "age": 49, "title": "COO & Member of Management Board", "yearBorn": 1975, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Renate  Gloggner", "age": 54, "title": "Executive VP of People & Community and Member of Management Board", "yearBorn": 1970, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Philippe  Legenne M.B.A., M.D.", "age": 58, "title": "Chief Medical Officer & Member of the Management Board", "yearBorn": 1966, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Daniel  Steiner Ph.D.", "title": "Senior Vice President of Research & Technology", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}], "compensationAsOfEpochDate": 1735603200, "executiveTeam": [], "maxAge": 86400, "priceHint": 4, "previousClose": 3.89, "open": 3.68, "dayLow": 3.68, "dayHigh": 3.8, "regularMarketPreviousClose": 3.89, "regularMarketOpen": 3.68, "regularMarketDayLow": 3.68, "regularMarketDayHigh": 3.8, "payoutRatio": 0.0, "beta": 0.428, "forwardPE": -2.0652173, "volume": 807, "regularMarketVolume": 807, "averageVolume": 2779, "averageVolume10days": 2480, "averageDailyVolume10Day": 2480, "bid": 0.0, "ask": 0.0, "bidSize": 0, "askSize": 0, "marketCap": 142090944, "fiftyTwoWeekLow": 3.36, "fiftyTwoWeekHigh": 7.6, "allTimeHigh": 32.04, "allTimeLow": 3.32, "priceToSalesTrailing12Months": 208.65044, "fiftyDayAverage": 3.68264, "twoHundredDayAverage": 4.137335, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": 29441948, "profitMargins": 0.0, "floatShares": 17482796, "sharesOutstanding": 37392355, "sharesShort": 34679, "sharesShortPriorMonth": 27566, "sharesShortPreviousMonthDate": 1756425600, "dateShortInterest": 1759190400, "sharesPercentSharesOut": 0.00090000004, "heldPercentInsiders": 0.0, "heldPercentInstitutions": 0.09731, "shortRatio": 13.65, "shortPercentOfFloat": 0.0019, "impliedSharesOutstanding": 37854181, "bookValue": 2.853, "priceToBook": 1.3319314, "lastFiscalYearEnd": 1735603200, "nextFiscalYearEnd": 1767139200, "mostRecentQuarter": 1751241600, "netIncomeToCommon": -64803000, "trailingEps": -2.23, "forwardEps": -1.84, "enterpriseToRevenue": 43.233, "enterpriseToEbitda": -0.496, "52WeekChange": -0.19999999, "SandP52WeekChange": 0.118204355, "quoteType": "EQUITY", "currentPrice": 3.8, "targetHighPrice": 17.042356, "targetLowPrice": 4.016662, "targetMeanPrice": 10.540455, "targetMedianPrice": 10.5514, "recommendationMean": 1.5, "recommendationKey": "strong_buy", "numberOfAnalystOpinions": 4, "totalCash": 114486000, "totalCashPerShare": 3.062, "ebitda": -59339000, "totalDebt": 1837000, "quickRatio": 9.156, "currentRatio": 9.348, "totalRevenue": 681000, "debtToEquity": 1.722, "revenuePerShare": 0.019, "returnOnAssets": -0.25530002, "returnOnEquity": -0.49424, "grossProfits": -42259000, "freeCashflow": -29910124, "operatingCashflow": -56657000, "grossMargins": 0.0, "ebitdaMargins": 0.0, "operatingMargins": -88.43465, "financialCurrency": "CHF", "symbol": "MOLN", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Nasdaq Real Time Price", "triggerable": true, "customPriceAlertConfidence": "HIGH", "longName": "Molecular Partners AG", "regularMarketChangePercent": -2.3136287, "regularMarketPrice": 3.8, "hasPrePostMarketData": true, "firstTradeDateMilliseconds": 1623850200000, "postMarketChangePercent": -2.63158, "postMarketPrice": 3.7, "postMarketChange": -0.0999999, "regularMarketChange": -0.09000015, "regularMarketDayRange": "3.68 - 3.8", "fullExchangeName": "NasdaqGS", "averageDailyVolume3Month": 2779, "fiftyTwoWeekLowChange": 0.44000006, "fiftyTwoWeekLowChangePercent": 0.1309524, "fiftyTwoWeekRange": "3.36 - 7.6", "fiftyTwoWeekHighChange": -3.8, "fiftyTwoWeekHighChangePercent": -0.5, "fiftyTwoWeekChangePercent": -19.999998, "earningsTimestamp": 1756152000, "earningsTimestampStart": 1756152000, "earningsTimestampEnd": 1756152000, "earningsCallTimestampStart": 1741345140, "earningsCallTimestampEnd": 1741345140, "isEarningsDateEstimate": false, "epsTrailingTwelveMonths": -2.23, "epsForward": -1.84, "epsCurrentYear": -1.51072, "priceEpsCurrentYear": -2.5153568, "fiftyDayAverageChange": 0.11735988, "fiftyDayAverageChangePercent": 0.03186841, "twoHundredDayAverageChange": -0.33733487, "twoHundredDayAverageChangePercent": -0.08153434, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "ipoExpectedDate": "2021-06-16", "averageAnalystRating": "1.5 - Strong Buy", "cryptoTradeable": false, "marketState": "CLOSED", "shortName": "Molecular Partners AG", "corporateActions": [], "postMarketTime": 1760135325, "regularMarketTime": 1760126400, "exchange": "NMS", "messageBoardId": "finmb_32677064", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EDT", "gmtOffSetMilliseconds": -14400000, "market": "us_market", "esgPopulated": false, "trailingPegRatio": null, "__fetch_time": "2025-10-11"}]